Pacira BioSciences (PCRX) Inventory Average (2011 - 2026)

Pacira BioSciences' Inventory Average history runs 16 years deep, the most recent figure standing at $151.6 million for Q1 2026.

• In Q1 2026, Inventory Average rose 17.06% year-over-year to $151.6 million; the TTM figure through Mar 2026 stood at $151.6 million (up 17.06% YoY), while the FY2025 annual figure was $139.1 million, up 21.12% from the prior year.
• Inventory Average was $151.6 million for Q1 2026 at Pacira BioSciences, down from $155.3 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $155.3 million in Q4 2025 to a low of $92.6 million in Q2 2023.
• Historically, Inventory Average has averaged $114.0 million across 5 years, with a median of $101.1 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Inventory Average jumped 57.27% in 2022, then slipped 9.37% in 2023.
• A 5-year view of Inventory Average shows it stood at $96.4 million in 2022, then grew by 4.15% to $100.4 million in 2023, then rose by 18.06% to $118.6 million in 2024, then surged by 30.95% to $155.3 million in 2025, then declined by 2.35% to $151.6 million in 2026.
• The last three Inventory Average figures came in at $151.6 million (Q1 2026), $155.3 million (Q4 2025), and $152.9 million (Q3 2025), per Business Quant data.